MongoDB reported second-quarter fiscal 2023 adjusted loss of -23 cents per share, beating the Zacks Consensus Estimate by 20.69%. The loss, however, is wider than the year-ago quarter’s -12 cents per share.
The database company’s revenues surged +52.8% year over year to $303.7 million, exceeding surpassing the consensus expectations by 8.38%.
Subscription revenues ( 96% of revenues) grew 52.4% year over year to $291.6 million, while Services revenues climbed +63.6% year over year to $12.1 million (4% to revenues).
MongoDB added 1,800 customers during the quarter, bringing the total to 37,000 as of quarter-end.
Atlas revenues surged +73% year over year (and is 64% to total revenues). Atlas added 1,800 customers during the quarter, to more than 35,500 customers as of quarter-end.
MongoDB’s gross margin expanded +100 basis points year-over-year basis to 73.5%.
For third-quarter fiscal 2023, MongoDB expects non-GAAP net loss between -16 cents and -19 cents per share. It predicts revenues of $300 million to $303 million.
For full fiscal year 2023, MongoDB projects non-GAAP net loss in the range of -28 cents and -35 cents per share. It expects revenues range of $1.196 billion to $1.206 billion.
MDB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 36 cases where MDB's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .
The RSI Indicator entered the oversold zone -- be on the watch for MDB's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The Moving Average Convergence Divergence (MACD) for MDB just turned positive on March 28, 2024. Looking at past instances where MDB's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MDB advanced for three days, in of 335 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Momentum Indicator moved below the 0 level on April 18, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on MDB as a result. In of 76 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MDB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for MDB entered a downward trend on April 15, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MDB’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock slightly better than average.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (24.272) is normal, around the industry mean (29.871). P/E Ratio (0.000) is within average values for comparable stocks, (155.580). Projected Growth (PEG Ratio) (1.654) is also within normal values, averaging (2.725). Dividend Yield (0.000) settles around the average of (0.081) among similar stocks. P/S Ratio (15.083) is also within normal values, averaging (55.249).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a developer of MongoDB database
Industry PackagedSoftware